Induction of Protein Kinase C8 Subspecies in Neurons and
Microglia After Transient Global Brain Ischemia Susanna Koponen, Gundars Goldsteins, Riitta Keinanen, and J ari Koistinaho A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland Summary: The delayed death of CAl neurons after global brain ischemia is associated with induction of apoptosis genes and is inhibited by protein synthesis inhibitors, suggesting that the degeneration of CAl pyramidal neurons is an active process that requires new gene expression. The transient global isch emia model has been extensively used to identify enzymes and other proteins underlying delayed neuronal cell death, The ex pression of protein kinase C (PKC) subspecies after 20 minutes of global brain ischemia produced by a four-vessel occlusion model in the rat was studied. From the multiple PKC subspe cies studied, only PKC8 mRNA was significantly up-regulated in CAl pyramidal neurons at 24 hours and in activated microg lia at 3 to at least 7 days after ischemia. The induction of PKC8 mRNA was also found in the cortex at 8 hours and Transient global ischemia causes neuronal death in various brain areas, including the CA 1 sector of the hip pocampus, dorsolateral part of the striatum, thalamus, and cortex (Pulsinelli et al., 1982; Jin et al., 1999) . The cell death in the CAl region is selective for neurons, robust, and delayed when compared with the ischemic damage in other brain regions (Pulsinelli et al., 1982; Jin et al., 1999) . Several studies have demonstrated that ap optosis, an important physiologic process requiring the activation of an intrinsic genetic program, is involved in ischemic cell death in the brain, particularly in the CAl pyramidal cells (MacManus et al., 1993; Du et al., 1996; Jin et al., 1999) . However, several hallmarks of apoptosis are not seen in CAl neurons after global ischemia (Mac-3 days after ischemia. This cortical but not hippocampal induc tion was regulated by an a-amino-3-hydroxy-5-methyl-4isoxazole propionic acidJkainate receptor antagonist, 6-nitro-7sulfamobenzo[flquinoxaline-2,3-dione, and glucocorticoids. An N-methyl-D-aspartate receptor antagonist, MK-801, was without effect on the induction of PKC8 subspecies. The se lective and prolonged induction of the PKC8 mRNA and pro tein first in CAl pyramidal neurons and at a later stage in activated microglia suggests that the PKC8 isozyme may take part in regulation of the delayed death of CAl neurons after transient global brain ischemia. Key Words: Global brain isch emia-Protein kinase C-Gene induction-In situ hybridiza tion-Apoptosis-Pharmacology. Manus et al., 1999) , suggesting that the cell death in volves atypical features of apoptosis or occurs mainly through necrosis. Altogether, the precise intrinsic mecha nisms underlying delayed neuronal cell death have not yet been elucidated, despite extensive studies. Because numerous genes involved in either apoptosis or neuronal survival are induced by brain ischemia (Koistinaho and Hokfelt, 1997) and inhibitors of protein synthesis pro vide protection against brain ischemia (Goto et aI., 1990) , expression of novel proteins is likely to play a role in delayed neuronal death.
Protein kinase C (PKC) is a family of serine-threonine kinases that have differential subcellular localization and requirements for their activation (Tanaka and Nishizuka, 1994) and are likely to mediate unique functions in vari ous cell types. Protein kinase C undergoes translocation from one intracellular compartment to another on acti vation (Mochly-Rosen and Gordon, 1998) , and isozyme specificity is partly mediated by association of each PKC isozyme with specific anchoring proteins (Mochly Rosen and Gordon, 1998)\ Ischemic insult induced by various global and focal brain ischemia models has been reported to result in a rapid loss of total PKC activity (Crumrine et al., 1990; Louis et al., 1991; Wieloch et al., 1991; Cardell and Wieloch, 1993; Busto et al., 1994) . In addition, PKC activity is reduced in cultured neurons exposed to neurotoxic levels of excitatory amino acids, and this inactivation has been suggested to be part of an N-methyl-D-aspartate (NMDA)-activated signaling path way necessary for cortical neurons to undergo delayed excitotoxic death (Durkin et aI., 1997) . In contrast, some studies have suggested that the activation of PKC is in volved in neuronal cell death (Hara et aI., 1990; Mattson, 1991; Kharlamov et aI., 1993) , and a sustained increase in total PKC activity and isoform-specific translocation and activation was recently reported to take place in both the hippocampus and the cerebellum after global incom plete cerebral ischemia in the dog (Sieber et aI., 1998) . Moreover, a Ca 2 + -independent member of the PKC fam ily, PKC3, has been shown to mediate apoptotic signal ing in both neuronal (Villalba, 1998) and nonneuronal (Emoto et aI., 1995) cells. However, only few studies have been directed to explore the changes in the expres sion of various PKC subspecies after ischemic insult. Global brain ischemia results in an induction of PKC3 and -� mRNAs in unknown cells of the gerbil forebrain (Savithiry and Kumar, 1994 ) and a transient up regulation followed by a decline in the PKCI' mRNA expression in the gerbil hippocampus (Zablocka et aI., 1998) . Finally, our previous studies have shown that ex pression of PKC3, but no other PKC subspecies, is up regulated in perifocal neurons by an NMDA-dependent mechanism after focal brain ischemia (Miettinen et aI., 1996) .
The aim of the present study was to demonstrate the pattern of postischemic changes in the expression of PKC subspecies at the mRNA and protein level after transient global forebrain ischemia and to determine the effects of pretreatment with dexamethasone, a synthetic glucocorticoid, MK-801, an NMDA receptor antagonist, and 6-nitro-7 -sulfamobenzo[f]quinoxaline-2,3-dione (NBQX), an ex-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)lkainate receptor antagonist, on PKC expression in the rat brain.
MATERIALS AND METHODS

Four-vessel occlusion
Transient forebrain ischemia was induced by a four-vessel occlusion model according to the method of Pulsinelli et a!. (1982) with modifications. In brief, male Wi star rats (2S0 to 270 g) were anesthetized with S% halothane and placed in a stereotaxic frame. The anesthesia was maintained on 1.0% halothane in 70% N 2 0/30% 0 2 ' and both vertebral arteries were occluded permanently by electrocauterization. On the fol lowing day, the rats were reanesthetized and the femoral artery was cannulated for recording of physiological parameters be fore and during ischemia. Rectal temperature was continuously monitored and kept at 37 to 37.SoC using a heating pad. The common carotid arteries were exposed bilaterally, and the an esthesia was discontinued. for 20 minutes, At various time points, the animals were de capitated and tissues processed for in situ hybridization, immu noblotting, or Northern blotting or the brains were perfusion fixed for immunohistochemistry. Sham-operated animals un derwent vertebral artery occlusion but during the following day were anesthetized without occlusion of the common carotid arteries.
Drug treatments
MK-801 hydrogen maleate (Research Biochemicals, Natick, MA, U.S.A.; 3 mg/kg intraperitoneally) and dexamethasone sodium phosphate (Decadron; MSD Isotopes, Haarlem, the Netherlands; 3 mg/kg intraperitoneally) were given 30 minutes before ischemia (n = 3/group), and the dexamethasone-treated animals received additional doses (3 mg/kg) I and 3 hours after ischemia. 6-Nitro-7 -sulfamobenzo[f]quinoxaline-2,3-dione (Tocris Cookson, Bristol, U.K.) was given intraperitoneally as two equal injections of a total dose of 60 mg/kg IS minutes before and I hour after ischemia. Control animals received an intraperitoneal injection of saline 30 minutes before ischemia.
In situ hybridization
For in situ hybridization studies, rats were decapitated at 4 hours, 8 hours, 24 hours, 3 days, and 7 days after ischemia (n = 3/group). The brains were rapidly frozen and sectioned at lO-fLm thickness. The synthetic oligonucleotides for PKC sub species were the same as previously used (Miettinen et a!., 1996) . Oligonucleotides with length and GC ratio similar to the corresponding antisense oligonucleotides but without homol ogy to any known gene sequences were used as controls. The probes were end-labeled with 3 5 S_ATP using terminal deoxy nucleotidyl transferase (MBI Fermentas, Vilnius Lithuania) and purified using a Probe Quant GSO column (Pharmacia Biotech, Sweden). The brain sections were hybridized overnight in hy bridization solution containing 10 x 10 6 cpmlmL probe, 40 fLL of S mollL dithiothreitol, SO fLL of 10 mg/mL salmon sperm DNA, and 900 fLL of hybridization cocktail [SO mL of form amide, 20 mL of 20 x saline-sodium citrate (SSC), 2 mL of SO x Denhardt's reagent, 10 mL of 0.2 mollL sodium phosphate buffer (pH 7.4), 10 g of dextran, 4 mL of 2S% sarcosyll. The sections were washed in 1 x SSC at SsoC for 2 hours, rinsed 2 x S minutes in deionized water at room temperature, dehy drated for 30 seconds in 60 and 90% ethanol, air dried, and covered with Kodak XAR-S film for 21 days.
Image analysis
The mRNA expression levels of PKC subspecies were quan tified by measuring the optical density of the specified brain regions using a digital image analysis system (MCID 4; Imag ing Research, St. Catherine's, Ontario, Canada). The gray lev els corresponding to the 14 C plastic standards (Amersham, Buckinghamshire, U.K.) lying within the exposure range of the film were detected and used as a fourth-degree polynomial approximation to construct a gray level to activity transfer. Densitometric measurements were done from four sections per each animal, and the data were assessed with the two-tailed Mann-Whitney UlWilcoxon rank sum W test.
Northern blotting
Total RNA was isolated from frozen cortical and hippocam pal tissues using Trizol reagent according to the manufacturer's instructions. Sample s of 20 fLg/lane were electrophoresed through a formaldehyde/1.2% agarose gel and transferred to a nylon membrane (Hybond-N; Amersham) by capillary blotting. The membrane was hybridized with a 3 2 p random prime labeled (Ready To Go DNA labeling kit; Pharmacia Biotech, Sweden) PKC8 cDNA (specific activity I x 109 cpm/J.Lg) in 5
x SSC/5 x Denhardt's/50% deionized formamidell % sodium dodecyl sulfate (SDS) overnight at 42°e. It was washed in 2 x SSC/D.l % SDS twice for 5 minutes at room temperature, in 0.2 x SSC/O. I % SDS twice for 5 minutes at room temperature, and for 10 minutes at 42°C and autoradiographed at -80°e. After stripping, the membrane was rehybridized with a 3 2 P-Iabeled �-actin cDNA (specific activity 8 x 108 cprn/J.Lg), as described above.
Immunohistochemistry
For immunohistochemistry, rats were perfused with 4% paraformaldehyde at 12 hours, 72 hours, and 7 days following the ischemia (n = 3/group), and the brains were postfixed for 4 hours in 4% paraforrnaldehyde. The vibratome sections (50 J.Lm) were incubated for 48 hours in the primary PKC8 antibody (rabbit, I: 1,000; GibcoBRL, Life Technologies, or Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), and the bound anti body was visualized with the avidin-biotin-peroxidase method (Vectastain kit; Vector Labs, Burlingame, CA, U.S.A.) using 3,3' -diaminobenzidine as the peroxidase substrate. For double staining studies, the brains were fixed 8 and 72 hours after ischemia and immersed in 20% sucrose buffer for 72 hours, frozen in liquid nitrogen-cooled isopentane, and cut at 14-J.Lm thickness in a cryostat. The sections were incubated for 48 hours at room temperature in a mixture of PKC8 (I :250; Santa Cruz Biotechnology) and mouse monoclonal OX-42 (I :250; Serotec, Oxford, U.K.) antibodies or PKC8 (1 :250) and mouse monoclonal glial fibrillary acidic protein (I :250; Boehringer Mannheim, Indianapolis, IN, U.S.A.) or PKC8 (1:250) and mouse monoclonal microtubule-associated protein-2 (1 :250; Boehringer-Mannheim) or PKC8 (1 :250) and SMI-31, the an tibody for phosphorylated heavy and medium molecular weight neurofilaments (1 :5,000; Sternberger Monoclonals, Baltimore, MD, U.S.A.) diluted in 0.1 mollL sodium phosphate buffer (pH 7.4), containing 0.3% Triton X-100 and I % bovine serum al bumin. Fluorescein isothiocyanate-conjugated anti-rabbit and tetramethylrhodamine isothiocyanate-conjugated anti-mouse IgGs (Jackson ImmunoR' esearch, West Grove, PA, U.S.A.) were used as secondary antibodies. The sections were cover slipped in glycerol/phosphate-buffered saline (3: I) and exam ined in a Leica DMRB microscope equipped with rhodamine and fluorescein isothiocyanate filter sets.
Immunoblotting
Three days after ischemia, sham-operated (n = 2) and isch emic (n = 4) rats were killed, and the hippocampi were quickly dissected out. The tissue was homogenized in I mmol/L Tris HCI buffer (pH 7.4), containing 320 mmol/L sucrose, 1 mm01/L ethyleneglycol bis(aminoethylether)tetraacetate, 5 mmollL dithiothreitol, I mmollL sodium vanadate, 50 mmol/L NaF, 0.2 mmollL phenyl methyl sulfonyl fluoride, 10 J.Lg/mL leupeptin, and 10 J.Lg/mL aprotinin. Fifty microliters of the buffer was added per 10 mg of wet tissue. Cell debris was removed by lO-minute centrifugation at 1,000 g. The cytosolic and membrane fractions were separated by ultracentrifugation for 60 minutes at 100,000 g. The pellet, containing membranes, was solubilized in homogenization buffer plus I % Triton X-100, and insoluble fraction was removed by centrifugation for 10 minutes at 10,000 g. Sodium dodecyl sulfate polyacryl amide gel electrophoresis Laemmli sample buffer was added to the cytosol and membrane fractions. The samples were incu bated at 100°C for 5 min. Electrophoresis was carried out in a 10% SDS-polyacrylamide gel in MiniProtean (Bio-Rad) appa ratus. A sample containing 20 J.Lg of total protein was loaded per lane. Separated proteins were transferred onto Hybond-P membrane (Amersham-Pharmacia Biotech) in a MiniTransBlot (Bio-Rad) wet blotting apparatus according to the manufactur er's instructions. The membranes were processed according to the manufacturer's instructions. Protein kinase C8 was detected using monoclonal (Transduction Laboratories; I :5,000) or rab bit polyclonal (Gibco; 1 :2,000) and secondary horseradish per oxidase-labeled antibody (Amersham-Pharmacia Biotech; I: 10,000 dilution), using an ECL Plus kit (Amersham Pharmacia Biotech). The membranes were directly scanned on a Storm (Molecular Dynamics, Sunnyvale, CA, U.S.A.) fluo roimager, and the detected bands quantified using Image Quant software.
RESULTS
Expression of protein kinase C mRNA after transient forebrain ischemia
In situ hybridization results revealed a basal expres sion of all PKC subspecies in control rats, as has been reported earlier (Miettinen et aI., 1996) . Protein kinase Ca showed the highest expression in cortical layers 2 and 3, whereas PKC(3, -E, and -� were more homoge neously distributed in all cortical layers. The expression of PKCy was seen in cortical layers 1, 3, and 5. A low expression of PKC'6 was detected in cortical layers 2, 3, and 5. The PKC isoforms a, (3, "/, E, and � showed mRNA expression in CAl to CA3 areas of the hippo- campus and in the dentate gyrus, whereas PKC8 ap peared to be the only PKC isoform studied that was not expressed at a detectable level in the hippocampus (Fig.  lA) . A strong basal hybridization signal of PKC8 mRNA was seen in the thalamus (Fig. 1 ). Figure 2 shows the time course of the PKC mRNA expression after transient global ischemia. The cortical expression of PKCa, -(), --y, -E, and -� was not signifi cantly changed at any time point studied after 20 minutes of global ischemia. In CA3, the level of PKCa mRNA was significantly lower at 24 hours after ischemia when compared with sham-operated animals. In CAl , the ex pression of PKC(), --y, -E, and -� mRNA was gradually decreased after ischemia. The reduction of all the sub species except PKCa reached a significant level by day 7. The mRNA level of PKCa was also slightly decreased after ischemia in the CA 1 but was not significantly dif ferent from values in sham-operated animals.
The only PKC subspecies that showed induction in response to ischemia was PKC8. Its mRNA expression showed a two-phase increase in the cortex, being signifi cantly higher at 8 hours and 3 days after ischemia when compared with control values (Fig. 2) . The expression of PKC8 was increased mainly in the most superficial lay ers of the frontoparietal and cingulate cortex (Figs. IB and 10) and remained up-regulated until 7 days (Fig. 2) . In the CAl area, PKC8 mRNA was also increased 8 hours after ischemia and remained significantly in creased until 7 days (Figs. IB to IE and 2). The expres sion of PKC8 was occasionally detected in the CA3 area at 8-and 24-hour time points (Figs. IB and lC) but not at 3 days after ischemia (Fig, 10) . We next studied whether NMOA-and AMP A-type glutamate receptors and glucocorticoids regulate the ischemia-induced expression of PKC8, the only subspe cies found to be up-regulated in the present study. Values for physiologic parameters determined before the isch emia were all within the normal range and did not sig nificantly differ between the treatment groups (Table 1 ). An NMOA receptor antagonist, MK-80l (3 mg/kg), had no effect on ischemia-induced PKC8 expression at the 8-hour time point but reduced cortical PKC() mRNA expression by 20% (Fig. 3 ). An AMPA receptor antago nist, NBQX (60 mg/kg), reduced the ischemia-induced expression of PKC8 in the cortex by 70% but did not An values are mean ± SD. There are no statisticany significant differences between the groups. reduce significantly the expression in CAL In addition, NBQX reduced hippocampal expression of PKCa mRNA by -35% but did not affect other PKC subspe cies. Treatment with dexamethasone, a synthetic gluco corticoid (3 x 3 mg/kg), inhibited significantly the in duction of PKC 'b mRNA in the cortex but not in the hippocampus and did not affect other PKC subspecies. The induction of the PKC 'b mRNA was confirmed by Northern blotting, which demonstrated a specific band of 3.l-kb size for PKC 'b ( Fig. 4) . Supporting the results of in situ hybridization, Northern blotting showed that PKC 'b mRNA was induced in the samples from the cor tex and hippocampus 24 hours after forebrain ischemia when compared with control samples. Control hybridiza tion of the same blots with l3-actin cDNA probe demon strated equal amounts of loaded RNAs (Fig. 4) .
Immunohistochemistry
The time course of PKC 'b immunoreactlvity in the cortex and hippocampus was studied in animals that sur vived for 12 hours, 72 hours, or 7 days after ischemia. In control animals, few PKC 'b -positive neurons were de-cortex hippocampus tected in the frontoparietal and cingulate cortex (Fig.  SB) , whereas no immunoreactive neurons were seen in the hippocampus (Fig. SA) . In addition, a large number of immunostained neurons were seen in the thalamus (not shown). Twelve hours after ischemia, the number of PKC8-positive neurons increased both in cortical layers 2 to 3 (Figs. SD and SE) and in layer S, and some im munostained neurons were observed in the CA 1 region of the hippocampus (Fig. SC) . At 3 days, a strong band of immunoreactive microglia-like cells was seen in the CAl pyramidal cell layer (Figs. 6A, 6B, and 6D) , which was still present 7 days after ischemia (Fig. 6C) . The double-staining experiments showed a colocaliza tion of PKC8 and microtubule-associated protein-2 anti bodies in neurons of the CA 1 pyramidal cell layer 8 hours after ischemia ( Figs. 7 A and 7B) . The PKC8positive cells did not stain with glial fibrillary acidic protein (Figs. 7C and 7D) or OX-42 antibody (not shown) at 8 hours. At 24 hours after ischemia, the PKC8 immunoreactivity colocalized with SMI-3J, the antibody detecting phosphorylated neurofilaments (Figs. 7E and 7F). By 3 days, the microtubule-associated protein-2 im munostaining had disappeared from the CA I area (not shown), and the PKC8-positive cells double-stained with OX-42 (Figs. 7G and 7H) but not with glial fibrillary protein ( Figs. 71 and 7J) or SMI-31 (not shown), indi cating that they represented activated microglia.
Immunoblotting
The immunoblots demonstrated the presence of PKC8 in both cytosolic and membrane fractions in each hippo campus (Fig. 8A) . In three of four animals, a 70% in crease in the membrane fraction was seen (Fig. 8B) , thus possibly reflecting increased activity of the PKC8 pres ent in the hippocampus 3 days after ischemia.
DISCUSSION
The main findings of this study were that of the mul tiple subspecies of the PKC family, only the PKC8 iso form is up-regulated in the vulnerable regions of the rat The immunoreactivity of CA 1 was detected in microglial-like cells (8), which is also shown in a higher magnification of the positive cells (0 ).
brain after transient global brain ischemia and that AMPA receptors and glucocorticoids regulate this spe cific induction in the cortex but not in the hippocampus. The PKC8 induction in neurons precedes neuronal death in the CA I area, and it is also found in the activated microglia present in the CA 1 region at the time the de layed neuronal death takes place (Pulsinelli et aI., 1982) .
Although many studies have suggested that activation of PKC is involved in neuronal cell death (Hara et aI., 1990; Mattson, 1991; Kharlamov et aI., 1993) , loss of PKC activity is also an essential step in excitotoxic cell death (Durkin et aI., 1997) . The controversy of the pre vious studies is most likely due to different activation pathways and roles of each PKC subspecies in neuronal survival. The fact that neither dexamethasone, which is thought to enhance ischemic death of CA 1 neurons (Koide et aI., 1986) , nor NBQX, which provides protec tion against ischemic death of the CAl neurons (Small and Buchan, 1997) , altered the early expression of PKC8 mRNA in the present study indicates that PKC8 induc tion in these neurons does not correlate with neuronal survival. Instead, the late peak in PKC8 expression with an association with membrane translocation was local ized in activated microglia in the areas of delayed neu ronal death. The role of microglial activation in delayed neuronal death is not clear, but activated microglia are involved in excitotoxicity and inflammation, both of which are components of ischemia pathogenesis (Rogove and Tsirka, 1998; Dirnagl et a!., 1999) .
To our knowledge, there is no previous study available on expression of the various PKC subspecies after tran sient global ischemia in the rat brain. The induction of PKC8 and -� mRNAs takes place in the gerbil forebrain 6 and 24 hours after 10 minutes of global brain ischemia (Savithiry and Kumar, 1994) . In the same ischemic model, PKCy mRNA is transiently up-regulated at 3 hours after 5 minutes of forebrain ischemia, while no significant changes in the amounts of PKCa and -131 mRNA occur (Zablocka et a!., 1998) . In the present study, most of the PKC mRNAs were eventually de creased in the CAl area, most likely as a consequence of local neuronal degeneration. Because most of the PKC subspecies are expressed in the neurons (Huang et a!., 1988; Ito et a!., 1990) , the decline in the expression of PKC isoforms after transient forebrain ischemia may be secondary to neuronal cell death. The remaining expression level of PKCa may therefore occur in either nonneuronal cells (Sieber et a!., 1998) or nonvulnerable CAl neurons.
The expression of Ca-dependent PKC isoforms was not changed in the cortex at any postischemic time points, whereas the expression of the PKCa mRNA was lower at 24 hours after ischemia in the CA3 area and the mRNA levels of PKC13 and -')' and the Ca-independent isoforms PKCE and -� were gradually decreased in the CAl after ischemia. Wieloch et a!. (1991) reported that PKC13rr and -')' but not PKCa isoforms are redistributed from the cytosol to cell membranes and down-regulated in the striatal samples from rats subjected to the two vessel occlusion plus hypotension model for 15 minutes, whereas 10 minutes of ischemia in gerbils was shown to cause a transient increase in PKCa and -"I protein ex pression at 4 hours of reperfusion in CAl (Yokota et aI., 1992) . In addition, considering that rapid loss of total PKC activity after ischemic insult has been reported (Crumrine et aI., 1990; Louis et aI., 1991; Cardell and Wieloch, 1993; Busto et aI., 1994) , variation of the mod els and animals used in the expression studies of PKC subspecies may be responsible for the differences be tween the reported data. Nevertheless, the results suggest that if the Ca-dependent subspecies do play a role in ischemic cell death, it is more likely due to reduced than enhanced enzyme activity of these isoforms. Because the changes in the expression of classic PKCs took place only at the time when cell death was already proceeding, it is conceivable that Ca-dependent subspecies do not have an active role in ischemic neuronal death.
The compounds used to study NMDA-and AMP A type glutamate receptors and glucocorticoids in this study did not influence the physiological parameters, thus not affecting the differences in the expression level of PKC isoforms. The expression of PKCl) was de creased significantly by the AMP A receptor antagonist NBQX in the cortical but not in the hippocampal CAl region. In addition, NBQX reduced hippocampal expres sion of PKCa mRNA. Even though we cannot exclude the possibility that the effects of NBQX are at least par tially due to decreased brain temperature (Nurse and Corbett, 1996) , this is unlikely, because the influence of NBQX on the expression of other PKC subspecies was not consistent. Treatment with dexamethasone inhibited the induction of PKCo mRNA in the cortex without af fecting other PKC subspecies, whereas the NMDA re ceptor antagonist MK-80l had no effect on PKCo ex pression but reduced the expression of PKCf3 mRNA in the cortex. The effect of MK-80l on PKCo after global brain ischemia is different from that in our previous re port in which it inhibited the PKCo induction after focal brain ischemia in the rat (Miettinen et aI., 1996) . In the focal brain ischemia model, several gene inductions may be caused by cortical spreading depression-like depolar izations and not by the ischemia-reperfusion phenom enon itself (Koistinaho and Htikfelt, 1997) . The differ ence in the ability of MK-801 to inhibit PKCo induction after focal ischemia may therefore be due to the blocked cortical spreading depression (Iijima et aI., 1992) .
In normal physiological conditions, PKCo expression is found exclusively in neurons in the rat brain. In pri mary cultures, rat microglia have been reported to ex press PKCa, -0, and E isoforms (Nakai et aI., 1999) , whereas in the normal brain in vivo, no PKC immuno reactivity has been detected in these cells. Protein kinase C activation increases intracellular Ca 2 + levels (Yoo et aI., 1996) and mediates cytokine-induced superoxide production (Chao et aI., 1995) in cultured human microg lia, increases synthesis of nitric oxide (Yoon et aI., 1994) , and triggers microglia-induced neurotoxicity (McMillian et aI., 1997) in rodent microglia. Whether PKCo induction in microglia promotes neuronal cell death in brain ischemia requires further investigation.
Our results show that a damaging insult to the brain tissue is able to induce the PKCo gene in cells in which it is not present under physiological conditions. Thus, totally new signal transduction pathways may become activated after appropriate challenge and contribute, for example, to inflammatory or neurotoxic responses in mi croglia.
